Diagnostic value of six plasma biomarkers in progressive supranuclear palsy, multiple system atrophy, and Parkinson’s disease
In this study, the plasma biomarkers NfL, GFAP, Aβ42, and Aβ40 exhibited high discriminatory diagnostic value in PD and APS, and could be used as clinically potential diagnostic biomarkers. Plasma biomarker combinations could improve the differential diagnostic efficacy in the comparisons of PD and APS.
Authors
- Qinyong Ye (ORCID: https://orcid.org/0000-0002-0021-0257)
- Xiaochun Chen (ORCID: https://orcid.org/0000-0002-9228-0198)
- Yiming Li (ORCID: https://orcid.org/0000-0002-3430-5270)
- Ying Chen (ORCID: https://orcid.org/0000-0001-6630-2747)
- Jieming Huang
Institutions
- Fujian Medical University (CN)
- Union Hospital (CN)
Publication Details
- Journal
- Clinica Chimica Acta
- Published
- 2024-09-21
- DOI
- https://doi.org/10.1016/j.cca.2024.119975
- Citations
- 16
- Primary Topic
- Parkinson's Disease Mechanisms and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 5.91
Funders
- Fuzhou Science and Technology Bureau
- Fujian Provincial Department of Science and Technology